Polysomy 8 Syndrome: A Distinct Clinical Entity Comprising of Myelomonocytic/Monocytic Lineage Involvement in Acute Leukemia

Volume: 3 Number: 2 June 1, 2019
  • Zeynep Yüce
  • Erdinç Yüksel
  • Melek Pehlivan
  • Ömür Gökmen Sevindik
  • İnci Alacacıoğlu
  • Oğuz Altungöz
EN

Polysomy 8 Syndrome: A Distinct Clinical Entity Comprising of Myelomonocytic/Monocytic Lineage Involvement in Acute Leukemia

Abstract

Purpose: Cytogenetic abnormalities have been proven to be among the most valuable prognostic indicators in leukemia, allowing the stratification of patients in risk groups. We describe a patient diagnosed as AML-M5, with myeloid sarcoma and tetrasomy 8 as the sole chromosomal abnormality. We confirm that the presence of polysomy 8 in myeloid lineage malignancies is associated with a distinct clinical entity comprising of myelomonocytic/monocytic lineage involvement, poor prognosis and high incidence of myeloid sarcoma. In aim to obtain a detailed description of this clinical entity, literature of polysomy 8 cases has been reviewed.Methods: Cytogenetic analysis was performed on bone marrow samples directly after aspiration and following 24 h short term culture. Fluorescence in situ hybridization FISH analyses were performed at complete remission stage on interphase nuclei from bone marrow.Results: Cytogenetic analyses revealed tetrasomy 8 as the sole karyotipic change in all metaphases. The presence of tetrasomy was confirmed with C-MYC 8q24 , AML1/ETO ETO-8q21 and chromosome 8 centromeric probe cocktail.Conclusion: Recognition of the polysomy 8 syndrome will allow for the development of a standardized approach to these patients; as well as stimulating further research into the biology of the disorder that will allow for the development of better therapeutic strategies

Keywords

References

  1. Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009;114:937–951. [CrossRef]
  2. Grimwade D, Hills RK, Moorman AV, et al.; National Cancer Research Institute Adult Leukaemia Working Group. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 2010;116:354–365. [CrossRef]
  3. Shaffer LG, Mc Gowan-Jordan J, Schmid M. ISCN 2013: an international system for human cytogenetic nomenclature. Basel: S. Karger; 2013.
  4. Kim J, Park TS, Song J, Lee KA, Lee SG, Cheong JW, Choi JR. Tetrasomy 8 in a patient with acute monoblastic leukemia. Korean J Lab Med 2008;28:262–266. [CrossRef]
  5. Aktas D, Tuncbilek E, Cetin M, Hicsonmez G. Tetrasomy 8 as a primary chromosomal abnormality in a child with acute megakaryoblastic leukemia: a case report and review of the literature. Cancer Genet Cytogenet 2001;126:166–168. [CrossRef]
  6. Sheila N, Sait J, Raza A, Sandberg. Tetrasomy of chromosome 8: An interesting and rare cytogenetic phenomenon in acute nonlymphocytic leukemia. Cancer Genet Cytogenet 1987;27:269– 271. [CrossRef]
  7. Shao J, Zhang L, Semenza JC, Beach B, Smith MT. Tetrasomy 8 detected by interphase cytogenetics in a child with acute lymphocytic leukemia. Cancer Genet Cytogenet 1996;92:135–140. [CrossRef]
  8. de Oliveira FM, Brandão RA, Leite-Cueva SD, et al. Tetrasomy 8 in a patient with chronic lymphocytic leukemia. Cancer Genet Cytogenet 2010;198:166–169. [CrossRef]

Details

Primary Language

English

Subjects

-

Journal Section

-

Authors

Zeynep Yüce This is me

Erdinç Yüksel This is me

Melek Pehlivan This is me

Ömür Gökmen Sevindik This is me

İnci Alacacıoğlu This is me

Oğuz Altungöz This is me

Publication Date

June 1, 2019

Submission Date

-

Acceptance Date

-

Published in Issue

Year 2019 Volume: 3 Number: 2

APA
Yüce, Z., Yüksel, E., Pehlivan, M., Sevindik, Ö. G., Alacacıoğlu, İ., & Altungöz, O. (2019). Polysomy 8 Syndrome: A Distinct Clinical Entity Comprising of Myelomonocytic/Monocytic Lineage Involvement in Acute Leukemia. Journal of Basic and Clinical Health Sciences, 3(2), 42-45. https://doi.org/10.30621/jbachs.2019.505
AMA
1.Yüce Z, Yüksel E, Pehlivan M, Sevindik ÖG, Alacacıoğlu İ, Altungöz O. Polysomy 8 Syndrome: A Distinct Clinical Entity Comprising of Myelomonocytic/Monocytic Lineage Involvement in Acute Leukemia. JBACHS. 2019;3(2):42-45. doi:10.30621/jbachs.2019.505
Chicago
Yüce, Zeynep, Erdinç Yüksel, Melek Pehlivan, Ömür Gökmen Sevindik, İnci Alacacıoğlu, and Oğuz Altungöz. 2019. “Polysomy 8 Syndrome: A Distinct Clinical Entity Comprising of Myelomonocytic Monocytic Lineage Involvement in Acute Leukemia”. Journal of Basic and Clinical Health Sciences 3 (2): 42-45. https://doi.org/10.30621/jbachs.2019.505.
EndNote
Yüce Z, Yüksel E, Pehlivan M, Sevindik ÖG, Alacacıoğlu İ, Altungöz O (June 1, 2019) Polysomy 8 Syndrome: A Distinct Clinical Entity Comprising of Myelomonocytic/Monocytic Lineage Involvement in Acute Leukemia. Journal of Basic and Clinical Health Sciences 3 2 42–45.
IEEE
[1]Z. Yüce, E. Yüksel, M. Pehlivan, Ö. G. Sevindik, İ. Alacacıoğlu, and O. Altungöz, “Polysomy 8 Syndrome: A Distinct Clinical Entity Comprising of Myelomonocytic/Monocytic Lineage Involvement in Acute Leukemia”, JBACHS, vol. 3, no. 2, pp. 42–45, June 2019, doi: 10.30621/jbachs.2019.505.
ISNAD
Yüce, Zeynep - Yüksel, Erdinç - Pehlivan, Melek - Sevindik, Ömür Gökmen - Alacacıoğlu, İnci - Altungöz, Oğuz. “Polysomy 8 Syndrome: A Distinct Clinical Entity Comprising of Myelomonocytic Monocytic Lineage Involvement in Acute Leukemia”. Journal of Basic and Clinical Health Sciences 3/2 (June 1, 2019): 42-45. https://doi.org/10.30621/jbachs.2019.505.
JAMA
1.Yüce Z, Yüksel E, Pehlivan M, Sevindik ÖG, Alacacıoğlu İ, Altungöz O. Polysomy 8 Syndrome: A Distinct Clinical Entity Comprising of Myelomonocytic/Monocytic Lineage Involvement in Acute Leukemia. JBACHS. 2019;3:42–45.
MLA
Yüce, Zeynep, et al. “Polysomy 8 Syndrome: A Distinct Clinical Entity Comprising of Myelomonocytic Monocytic Lineage Involvement in Acute Leukemia”. Journal of Basic and Clinical Health Sciences, vol. 3, no. 2, June 2019, pp. 42-45, doi:10.30621/jbachs.2019.505.
Vancouver
1.Zeynep Yüce, Erdinç Yüksel, Melek Pehlivan, Ömür Gökmen Sevindik, İnci Alacacıoğlu, Oğuz Altungöz. Polysomy 8 Syndrome: A Distinct Clinical Entity Comprising of Myelomonocytic/Monocytic Lineage Involvement in Acute Leukemia. JBACHS. 2019 Jun. 1;3(2):42-5. doi:10.30621/jbachs.2019.505